Business
Oncothyreon to present at Invest Northwest 2009
SEATTLE, March 13 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company spec...
About this update from Cascade Copper Corp.
[{"type":"text","content":"\n\n\n\nSEATTLE, March 13 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a\nbiotechnology company specializing in the development of innovative\ntherapeutic products for the treatment of cancer, today announced that Robert\nKirkman, M.D., President and Chief Executive Officer, will present at the\nInvest Northwest 2009 Conference at 9:40 a.m. Eastern Time on Wednesday, March\n18, 2009.\n\n\nA live and archived webcast of Dr. Kirkman's presentation can be accessed\nat www.oncothyreon.com under the "News & Events" section.\n\n\nAbout Oncothyreon\n\n\nOncothyreon is a biotechnology company specializing in the development of\ninnovative therapeutic products for the treatment of cancer. Oncothyreon's\ngoal is to develop and commercialize novel synthetic vaccines and targeted\nsmall molecules that have the potential to improve the lives and outcomes of\ncancer patients. For more information, visit www.oncothyreon.com.\n\n\n","length":994,"tagName":"div"}]